BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8834953)

  • 21. Etoposide plus cisplatin followed by thoracic radiation for stage IIIB non-small cell lung cancer: MAOP study 2188.
    Lokich J; Auerbach M; Essig L; Fryer J; Fryer D
    J Infus Chemother; 1995; 5(2):70-2. PubMed ID: 8521238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group.
    Huber RM; Flentje M; Schmidt M; Pöllinger B; Gosse H; Willner J; Ulm K;
    J Clin Oncol; 2006 Sep; 24(27):4397-404. PubMed ID: 16983107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction chemotherapy with and without recombinant human granulocyte colony-stimulating factor support in locally advanced stage IIIA/B non-small cell lung cancer.
    Fischer JR; Manegold C; Bülzebruck H; Vogt-Moykopf I; Drings P
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):20-7. PubMed ID: 7516094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trial.
    Pöttgen C; Eberhardt WE; Gauler T; Krbek T; Berkovic K; Jawad JA; Korfee S; Teschler H; Stamatis G; Stuschke M
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):809-15. PubMed ID: 19427744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504.
    Gandara DR; Chansky K; Albain KS; Leigh BR; Gaspar LE; Lara PN; Burris H; Gumerlock P; Kuebler JP; Bearden JD; Crowley J; Livingston R;
    J Clin Oncol; 2003 May; 21(10):2004-10. PubMed ID: 12743155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer.
    Hirose T; Mizutani Y; Ohmori T; Ishida H; Hosaka T; Ando K; Shirai T; Okuda K; Ohnishi T; Horichi N; Kubota H; Adachi M
    Cancer Chemother Pharmacol; 2006 Sep; 58(3):361-7. PubMed ID: 16331494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cisplatin and weekly docetaxel with concurrent thoracic radiotherapy for locally advanced stage III non-small-cell lung cancer.
    Nakamura M; Koizumi T; Hayasaka M; Yasuo M; Tsushima K; Kubo K; Gomi K; Shikama N
    Cancer Chemother Pharmacol; 2009 May; 63(6):1091-6. PubMed ID: 18818921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of combined modality therapy with concurrent topotecan plus radiotherapy followed by consolidation chemotherapy for unresectable stage III and selected stage IV non-small-lung cancer.
    Seung SK; Ross HJ
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):802-9. PubMed ID: 18762390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Twice daily irradiation increases locoregional control in patients with medically inoperable or surgically unresectable stage II-IIIB non-small-cell lung cancer.
    Liao Z; Komaki R; Stevens C; Kelly J; Fossella F; Lee JS; Allen P; Cox JD
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):558-65. PubMed ID: 12062597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-treatment prognostic factors in patients with stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy.
    Jeremic B; Shibamoto Y
    Lung Cancer; 1995 Aug; 13(1):21-30. PubMed ID: 8528637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pilot study of accelerated hyperfractionated thoracic radiation therapy plus concomitant etoposide and cisplatin chemotherapy in patients with unresectable stage III non-small-cell carcinoma of the lung.
    Shaw EG; McGinnis WL; Jett JR; Su JQ; Frank AR; Mailliard JA; Engel RE; Wiesenfeld M; Rowland KM
    J Natl Cancer Inst; 1993 Feb; 85(4):321-3. PubMed ID: 8381189
    [No Abstract]   [Full Text] [Related]  

  • 32. Simultaneous chemoradiation in advanced non-small cell lung cancer.
    Pisch J; Malamud S; Harvey J; Beattie EJ
    Semin Surg Oncol; 1993; 9(2):120-6. PubMed ID: 8387689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inoperable non-small cell lung cancer: radiation with or without chemotherapy.
    Mattson K; Holsti LR; Holsti P; Jakobsson M; Kajanti M; Liippo K; Mäntylä M; Niitamo-Korhonen S; Nikkanen V; Nordman E
    Eur J Cancer Clin Oncol; 1988 Mar; 24(3):477-82. PubMed ID: 2838288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of institutional experience on survival outcome of patients undergoing combined chemoradiation therapy for inoperable non-small-cell lung cancer.
    Lee JS; Scott CB; Komaki R; Ettinger DS; Sause WT
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):362-70. PubMed ID: 11872281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life of inoperable non-small cell lung carcinoma. A randomized phase II clinical study comparing radiotherapy alone and combined radio-chemotherapy.
    Minet P; Bartsch P; Chevalier P; Raets D; Gras A; Dejardin-Closon MT; Lennes G
    Radiother Oncol; 1987 Mar; 8(3):217-30. PubMed ID: 3033751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer.
    Jeremic B; Shibamoto Y; Acimovic L; Milisavljevic S
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):521-5. PubMed ID: 9231675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of small doses of radiotherapy combined with chemotherapy in non-small cell lung cancer.
    Dionet C; Verrelle P; Roux D; Fraysse P; Achard JL; Beaupain R; Rozan R
    Antibiot Chemother (1971); 1988; 41():163-7. PubMed ID: 2854436
    [No Abstract]   [Full Text] [Related]  

  • 38. Is control of the primary tumour worthwhile in non-oat cell carcinoma of the bronchus?
    Saunders MI
    Clin Oncol (R Coll Radiol); 1991 Jul; 3(4):185-8. PubMed ID: 1657111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiotherapy combined with nimustine hydrochloride and etoposide for malignant gliomas: results of a pilot study.
    Tanaka M; Shibui S; Nomura K; Nakanishi Y
    Jpn J Clin Oncol; 2001 Jun; 31(6):246-50. PubMed ID: 11463801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychological evaluation of patients with inoperable non-small cell lung cancer treated with combination chemotherapy or radiotherapy.
    Kaasa S; Olsnes BT; Mastekaasa A
    Acta Oncol; 1988; 27(3):241-6. PubMed ID: 3415853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.